Navigation Links
BioMed Realty Trust Reports Third Quarter 2008 Financial Results
Date:10/29/2008

7,665 58,525 54,556

General and

administrative 4,589 5,283 16,428 15,990

Total expenses 49,885 40,816 136,246 125,868

Income from

operations 30,926 24,016 82,694 76,192

Equity in net loss

of unconsolidated

partnerships (208) (261) (338) (694)

Interest income 110 239 370 809

Interest expense (13,035) (7,043) (28,600) (21,013)

Income from

continuing

operations

before minority

interests 17,793 16,951 54,126 55,294

Minority interests

in continuing

operations of

consolidated

partnerships (11) 51 (4) (61)

Minority interests in

continuing

operations of

operating

partnership (559) (545) (1,767) (1,821)

Income from

continuing

operations 17,223 16,457 52,355 53,412

Income from

discontinued

operations before

(loss)/gain on sale

of assets and

minority interests - - - 639

(Loss)/gain on sale

of real estate assets - (1) - 1,087

Minority interests

attributable to

discontinued

operations - - - (74)

(Loss)/income

from

discontinued

operations - (1) - 1,652

Net income 17,223 16,456 52,355 55,064

Preferred stock

dividends (4,241) (4,241) (12,
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
9. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
10. Environmental Tectonics Corporations BioMedical Division Announces New Contract
11. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
(Date:12/19/2014)... Charm Sciences is pleased to announce ... of Aflatoxin M1 in raw commingled milk is the ... validation. The peer reviewed report of the validation by ... Agricultural and Fisheries Research (ILVO-T&V) has been published by ... the most toxic aflatoxin and a known carcinogen, can ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of ... Nick Maroulis, Pharm.D. to the newly created position of ... this position, Dr. Maroulis will continue to manage the ... our multi-site pharmacies as the company expands. Dr. Maroulis ... time he has served in many different capacities in ...
(Date:12/19/2014)... EVANSTON, Ill. , Dec. 19, 2014 ... to develop novel drugs for diseases of the central ... Ph.D., president and chief executive officer, will present at ... Dr. Riedel,s presentation will take place at 3:00 p.m. ... St. Francis in San Francisco, Calif. ...
Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... COLLEGE PARK, Md., Dec. 23, 2010 Martek Biosciences, ... Institute (Mtech) at the University of Maryland, entered an ... Dutch company Royal DSM NV for $1.1 billion, the ... Martek is the second company sold ...
... Pathfinder LLC, a private biotechnology company focused on ... ("Pathfinder"), and SyntheMed, Inc. (OTC Bulletin Board: ... today announced that they have entered into a definitive ... Cell Therapy, Inc." and the combined company will operate ...
... University of Santiago de Compostela (USC) have analysed levels of ... Galicia. The results show that 34% of these schools exceed ... Excessive inhalation of radon is associated with lung cancer. ... 34% had radon levels in excess of 400 Bequerels/m3 in ...
Cached Biology Technology:Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 2Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 3Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 4Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement 2Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement 3Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement 4Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement 5Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement 634 percent of Galician secondary schools exceed maximum recommended radon levels 2
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... developed from plant biomass and purpose-grown crops can substantially ... report says, but only through the wise allocation of ... the state. That,s the conclusion of "California Energy ... California Council on Science and Technology (CCST) co-authored by ...
... proposed an answer to the long-running debate as to how ... core-driven magnetic field, oceans of liquid water, dynamic climate and ... known Universe. Life arose on Earth over three and a ... planetary scale calamities such as the impacts of massive meteorites, ...
... Methanosarcina acetivorans lives off everything it can metabolize ... is not yet clear. Scientists at the Ruhr-Universitt Bochum ... USA have identified a protein that might act as ... and found both similarities and differences to the system ...
Cached Biology News:Biofuels will play integral role in California's energy future, says new EBI study 2Biofuels will play integral role in California's energy future, says new EBI study 3New study proposes solution to long-running debate as to how stable the Earth system is 2How Archaea might find their food 2
... is produced by a patented microwave process ... more consistent, even cell attachment, increased cell ... and growth uunder difficult conditions, including reduced ... provide a more ecominic alternative to expensive ...
...
Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
Biology Products: